Previous 10 | Next 10 |
Kintara Therapeutics to Present at the LD Micro Main Event XVI Conference PR Newswire SAN DIEGO , Oct. 2, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of ne...
Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting PR Newswire SAN DIEGO , Sept. 25, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
2023-09-19 00:34:34 ET More on Kintara Therapeutics Seeking Alpha’s Quant Rating on Kintara Therapeutics Historical earnings data for Kintara Therapeutics Financial information for Kintara Therapeutics For further details see: Kintara Therapeutics ...
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update PR Newswire SAN DIEGO , Sept. 18, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused ...
Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting PR Newswire SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company fo...
Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023 PR Newswire SAN DIEGO , Aug. 17, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintar...
Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C. PR Newswire SAN DIEGO , July 19, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company fo...
2023-06-30 08:41:13 ET Unicycive Therapeutics ( UNCY ) -26% regulatory update on Lanthanum Dioxycarbonate program . Paltalk ( PALT ) -21% . Root ( ROOT ) -18% on not receiving actionable offer . Eco Wave Power Global ( WAVE ) -17% . ...
2023-06-29 08:29:48 ET Eco Wave Power ( WAVE ) +56% . RenovoRx ( RNXT ) +24% . Kintara Therapeutics ( KTRA ) +22% . Intelligent Living Application ( ILAG ) +15% . Joby Aviation ( JOBY ) +14% rallies 10% to new 52-week h...
News, Short Squeeze, Breakout and More Instantly...
Kintara Therapeutics Inc Com Company Name:
KTRA Stock Symbol:
NASDAQ Market:
Kintara Therapeutics Inc Com Website:
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor PR Newswire KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remod...
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutic...